Designer Drugs, a locally owned and operated out of Chattanooga compounding pharmacy specializing in high-quality custom pharmaceuticals, has announced its participation at Vision Expo West 2019.
The company will join 15,000 other professionals in Las Vegas on September 18-21 at one of the nation’s largest optical conferences, featuring its low-dose atropine formulations and patented CatarActive3 (moxifloxacin/bromfenac/dexamethasone ophthalmic solution).
"Designer Drugs pharmacy designed and patented a unique eye drop that took the three-bottle eye drop regime after cataract surgery down to one drop. It is a huge breakthrough in cataract medicine," officials said.
Designer Drugs owner and developer of CatarActive3, Randy Davis, will be available at Booth #MS9114 to discuss these and other unique ophthalmic formulations.
Prescribing information will be provided at the booth throughout the conference.